Todd C. Brady, President and CEO at Aldeyra Therapeutics, Inc. (ALDX), bought 44,446 shares at $4.50 ($200K) on 2017-02-17, disclosed to the SEC on 2017-02-21.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $4.50 | 22,223 | $100K | 50.0% |
| 2 | $4.50 | 22,223 | $100K | 50.0% |
| Total | $4.50 avg | 44,446 | $200K | 100% |
| Filing → |
| ALDX | BUY | 2022-06-27 | $59K | — | Filing → |
| ALDX | BUY | 2019-12-18 | $102K | — | Filing → |
| ALDX | BUY | 2019-10-02 | $49K | — | Filing → |